Inspire Medical Systems Inc
$ 58.89
-2.00%
06 Aug - close price
- Market Cap 1,702,532,000 USD
- Current Price $ 58.89
- High / Low $ 60.44 / 58.68
- Stock P/E 13.00
- Book Value 27.51
- EPS 4.53
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.18 %
- 52 Week High 147.03
- 52 Week Low 38.91
About
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.
Analyst Target Price
$60.33
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-03 | 2026-05-04 | 2026-02-11 | 2025-11-03 | 2025-08-04 | 2025-05-05 | 2025-02-10 | 2024-11-04 | 2024-08-06 | 2024-05-07 | 2024-02-06 | 2023-11-07 |
| Reported EPS | 0.14 | 0.1 | 1.65 | 0.38 | 0.45 | 0.1 | 1.15 | 0.6 | 0.32 | -0.34 | 0.49 | -0.29 |
| Estimated EPS | -0.22 | -0.26 | 0.68 | -0.17 | 0.2 | -0.23 | 0.72 | 0.08 | -0.11 | -0.67 | -0.09 | -0.57 |
| Surprise | 0.36 | 0.36 | 0.97 | 0.55 | 0.25 | 0.33 | 0.43 | 0.52 | 0.43 | 0.33 | 0.58 | 0.28 |
| Surprise Percentage | 163.6364% | 138.4615% | 142.6471% | 323.5294% | 125% | 143.4783% | 59.7222% | 650% | 390.9091% | 49.2537% | 644.4444% | 49.1228% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INSP
2026-08-06 14:12:43
Inspire Medical Systems (NYSE:INSP) saw an 18% stock price increase after beating Q2 revenue expectations by 3.1% and reporting a statutory profit of US$0.01. Despite this, analysts forecast a revenue reduction for 2026 and expect the company to incur losses, yet they raised the average price target by 17%. The company's revenue is predicted to decline while the broader industry is set to grow, suggesting Inspire Medical Systems will lag its peers.
2026-08-05 07:13:44
Inspire Medical Systems (INSP) saw its stock jump 23% after reporting Q2 earnings, despite a 7.6% revenue slip due to coding and reimbursement issues. The company returned to a small quarterly profit of US$0.01 per share and achieved positive operating cash flow, along with announcing a restructuring plan (Project Horizon) to create US$30m in annual investment capacity. Bulls focus on the company's platform strength and self-funding growth, while bears highlight ongoing reimbursement disruptions and execution risks.
2026-08-05 02:13:44
Inspire Medical Systems' Chief People Officer, Melissa Mann, filed a Form 4 detailing tax-withholding dispositions related to the vesting of Restricted Stock Units (RSUs). A total of 652 shares were withheld across two transactions on July 31, 2025, and July 31, 2026, to cover tax obligations. These were not open-market sales but rather standard tax處理 for RSU vesting.
2026-08-04 16:41:40
Inspire Medical Systems (INSP) shares surged by 18.3% after the company reported better-than-expected quarterly results, raised its full-year guidance, and announced a new corporate restructuring initiative called Project Horizon. Oppenheimer upgraded the stock to Outperform with an $85 price target. This positive news follows a previous period of significant decline for the stock due to lowered forecasts in 2025.
2026-08-04 16:41:39
Inspire Medical Systems (INSP) has experienced a significant stock price decline over the past three years, yet current valuations suggest the shares are either fairly valued or undervalued. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $56 per share, indicating the stock trades at a modest 7% discount. Furthermore, its P/E ratio of 11.5x is below the industry average and a tailored fair P/E of 15.2x, pointing to an undervalued stock based on earnings.
2026-08-04 09:10:49
JP Morgan has increased its target price for Inspire Medical Systems Inc (INSP.N) to $60 from $54. This update reflects the analyst's revised outlook on the company's valuation. The article is a brief news alert from Reuters regarding this financial adjustment.
